IndustryStartup
Credibility rating
ValuationNot disclosed
LocationSan Francisco, United States
Total funding$3B
Founded2022
EmployeesNot disclosed
Financial performance
Company websiteFY26E
SCALE SIGNALNot disclosed insufficient data
CAPITAL ($)$3B Series A $3B
Insufficient history
The startup source files include current funding, valuation, team, and source fields, but not a historical revenue/profit series.
REVENUE GROWTHVALUE
1Y (TTM)Not disclosed
3Y CAGRNot disclosed
PROFIT GROWTHVALUE
1Y (TTM)Not disclosed
3Y CAGRNot disclosed
About
Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose. The company was started in 2022.
Startup profiles use public-source metrics where available. When a company only exposes partial financials, unavailable growth and leadership fields are marked as Not disclosed.
Financial signals
Total funding$3BSource field
Latest round$3BSeries A
ValuationNot disclosedWhen available
RevenueNot disclosedRevenue or run rate
Completeness5/111 source records